New Line of Non-CBD Topical Products on Store
Shelves by April
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQB:CBDHF) (FWB:8OO)
(“HempFusion” or the “Company”), a leading health and wellness
company offering premium probiotic supplements and products
containing CBD, is pleased to announce a major distribution
agreement with one of the largest retailers in the United States.
Products from the Company’s wholly-owned subsidiary, Sagely
Enterprises, Inc. (“Sagely Naturals”), are expected to be on store
shelves at over 3,700 of this retailer’s locations by April 2022.
The additional locations will increase the Company’s footprint from
roughly 18,000 doors to just under 22,000 locations, including nine
of the nation’s 10 largest Food, Drug & Mass retailers. Since
launching its new line of non-CBD topical OTC pain relief products,
Sagely Naturals has seen strong initial uptake, striking
distribution agreements with some of the nation’s largest
retailers.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20220310005364/en/
Sagely Naturals Non-CBD Topical OTC Pain
Relief Products (Photo: Business Wire)
“Through this distribution agreement alone, HempFusion will
exceed its distribution expansion for all of 2021 as we continue to
position the Company as a leading health and wellness business in
the US,” said Jason Mitchell, N.D., co-founder and Chief Executive
Officer of HempFusion. “With an initial launch into 75% of this
large US retailer’s stores, HempFusion has the opportunity to
introduce our premium wellness products to their millions of loyal
consumers who consider this retailer synonymous with ‘America,’”
continued Dr. Mitchell.
While much of the CBD industry continues to stall, HempFusion’s
diversified portfolio of health and wellness brands and products
has positioned the Company for significant growth in 2022 and the
years ahead. Big box retail remains a focus of the Company, as it
provides a significant strategic position for the Company in the
event of regulatory change.
ABOUT HEMPFUSION
One of a select few hemp-derived CBD companies that are today
fully prepared to meet or exceed expected global guidance,
HempFusion Wellness Inc. is a leading health and wellness company
whose family of premium consumer brands includes HempFusion™,
Sagely Naturals™, Apothecanna™, and Probulin Probiotics™, one of
the fastest-growing probiotics companies in the United States
according to SPINs reported data.
Among a handful of CBD companies to have achieved Self-Affirmed
GRAS status, the HempFusion family of brands’ product portfolio
comprises 112 SKUs including USDA Organic Certified Tinctures,
proprietary FDA Drug Listed Over-The-Counter (OTC) Topicals,
probiotic supplements and skin care products, a White Label
division and more. With a strong focus on research and development,
HempFusion Wellness has 43 products under development.
Available from nearly 22,000 US retail locations across all 50
states, HempFusion Wellness products are also available in China,
Mexico, Ireland, United Kingdom, United Arab Emirates, South Korea
and Canada and may be purchased online from each brand’s website,
The Probulin Store on Amazon.com, Alibaba’s Tmall.com, the world’s
largest cross-border online marketplace, and a multitude of
additional e-commerce sites.
For more information, visit www.hempfusion.com.
Follow HempFusion on Twitter, Facebook and Instagram.
FORWARD-LOOKING STATEMENTS
This news release contains forward-looking statements and
forward-looking information within the meaning of Canadian
securities legislation (collectively, “forward-looking statements“)
that relate to HempFusion’s current expectations and views of
future events. Any statements that express, or involve discussions
as to, expectations, beliefs, plans, objectives, assumptions or
future events or performance (often, but not always, through the
use of words or phrases such as “will likely result,” “are expected
to,” “expects,” “will continue,” “is anticipated,” “anticipates,”
“believes,” “estimated,” “intends,” “plans,” “forecast,”
“projection,” “strategy,” “objective” and “outlook”) are not
historical facts and may be forward-looking statements and may
involve estimates, assumptions and uncertainties which could cause
actual results or outcomes to differ materially from those
expressed in such forward-looking statements. No assurance can be
given that these expectations will prove to be correct and such
forward-looking statements included in this news release should not
be unduly relied upon. These statements speak only as of the date
of this news release. In particular and without limitation, this
news release contains forward-looking statements relating to the
launch of the Sagely Naturals products at the retailer’s stores by
April 2022, the Company’s growth and expansion plans and the
Company’s other plans, focus and objectives.
Forward-looking statements are based on a number of assumptions
and are subject to a number of risks and uncertainties, many of
which are beyond HempFusion’s control, which could cause actual
results and events to differ materially from those that are
disclosed in or implied by such forward-looking statements. Such
risks and uncertainties include, but are not limited to, the impact
and progression of the COVID-19 pandemic and other factors set
forth under “Cautionary Note Regarding Forward-Looking Statements”
and “Risk Factors” in the annual information form of the Company
dated March 31, 2021, and available under the Company’s profile on
SEDAR at www.sedar.com. HempFusion undertakes no obligation to
update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise, except as
may be required by law. New factors emerge from time to time, and
it is not possible for HempFusion to predict all of them or assess
the impact of each such factor or the extent to which any factor,
or combination of factors, may cause results to differ materially
from those contained in any forward-looking statement. Any
forward-looking statements contained in this news release are
expressly qualified in their entirety by this cautionary
statement.
Neither the TSX nor its Regulation Services Provider (as that
term is defined in the policies of the TSX) accepts responsibility
for the adequacy or accuracy of this release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220310005364/en/
Investor Relations: Eric Balshin +1 437-826-9911
eric@sophiccapital.com
Company Contact: Jason Mitchell, N.D. Chief Executive Officer
and Director ir@hempfusion.com
HempFusion Wellness (TSX:CBD.U)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025
HempFusion Wellness (TSX:CBD.U)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025
